These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 6688182
1. In vivo and in vitro effects of nafazatrom (Bay g 6575), an antithrombotic compound, on arachidonic acid metabolism in platelets and vascular tissue. Fischer S, Struppler M, Weber PC. Biochem Pharmacol; 1983 Jul 15; 32(14):2231-6. PubMed ID: 6688182 [Abstract] [Full Text] [Related]
2. Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom. Marnett LJ, Siedlik PH, Ochs RC, Pagels WR, Das M, Honn KV, Warnock RH, Tainer BE, Eling TE. Mol Pharmacol; 1984 Sep 15; 26(2):328-35. PubMed ID: 6434940 [Abstract] [Full Text] [Related]
3. Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease. Buchanan MR, Butt RW, Turpie AG. Am Heart J; 1987 May 15; 113(5):1133-7. PubMed ID: 2953219 [Abstract] [Full Text] [Related]
13. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Bednar M, Smith B, Pinto A, Mullane KM. Circ Res; 1985 Jul 01; 57(1):131-41. PubMed ID: 2988818 [Abstract] [Full Text] [Related]
14. Nafazatrom (BAY g 6575), a potent stimulator of prostacyclin release from cardiac and renal vessel wall. Klitzke AK. Arch Int Pharmacodyn Ther; 1984 Oct 01; 271(2):220-8. PubMed ID: 6391401 [Abstract] [Full Text] [Related]
15. Antithrombotic activity of garlic: its inhibition of the synthesis of thromboxane-B2 during infusion of arachidonic acid and collagen in rabbits. Ali M, Thomson M, Alnaqeeb MA, al-Hassan JM, Khater SH, Gomes SA. Prostaglandins Leukot Essent Fatty Acids; 1990 Oct 01; 41(2):95-9. PubMed ID: 2274570 [Abstract] [Full Text] [Related]
16. Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Vericel E, Croset M, Sedivy P, Courpron P, Dechavanne M, Lagarde M. Thromb Res; 1988 Feb 01; 49(3):331-42. PubMed ID: 3129819 [Abstract] [Full Text] [Related]
17. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs. Maguire MH, Csonka-Khalifah L. Biochim Biophys Acta; 1987 Oct 17; 921(3):426-36. PubMed ID: 3117116 [Abstract] [Full Text] [Related]
18. Clinical study of a new antimetastatic compound, Nafazatrom (Bay g 6575). Effects on platelet consumption and monocyte prostaglandin production in patients with advanced cancer. Warrell RP, Bockman RS, Staszewski H, Maiese K. Cancer; 1986 Apr 15; 57(8):1455-60. PubMed ID: 2936443 [Abstract] [Full Text] [Related]
19. Platelet aggregation in arterioles of the hamster cheek pouch and in heart transplants: its tissue-dependent influencibility by acetylsalicylic acid and nafazatrom. Herrmann KS, Seuter F. Haemostasis; 1984 Apr 15; 14(3):281-7. PubMed ID: 6381254 [Abstract] [Full Text] [Related]
20. [Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets]. Yu W, Xu L. Yao Xue Xue Bao; 1998 Apr 15; 33(1):62-3. PubMed ID: 11938938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]